Zaltrap IV infusion 200mg, manufactured by Sanofi, contains Aflibercept beta (genetical recombination), a recombinant fusion protein. Marketed as Zaltrap, it is used in combination with chemotherapy for metastatic colorectal cancer. This 200mg 8mL 1 bottle has a YJ code of 4291436A2020.
Zaltrap IV infusion 200mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →